scPharmaceuticals Inc.
SCPHDelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001604950
scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in scPharmaceuticals Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +1 vs. Q1 2022
- Shares held
- 15.7M
- −187.7K (−1.2%) vs. Q1 2022
- Total value
- $75.9M
- −$14.2M (−15.7%) vs. Q1 2022
- New holders
- 4
- 16 more added
- Sold out
- 3
- 10 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SCPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 110 | $232.3M |
| Q2 2025 | 98 | $145.7M |
| Q1 2025 | 88 | $98.7M |
| Q4 2024 | 86 | $140.8M |
| Q3 2024 | 95 | $169.8M |
| Q2 2024 | 77 | $121.0M |
| Q1 2024 | 76 | $134.2M |
| Q4 2023 | 81 | $175.4M |
| Q3 2023 | 73 | $213.1M |
| Q2 2023 | 81 | $290.8M |
| Q1 2023 | 63 | $223.2M |
| Q4 2022 | 59 | $153.5M |
| Q3 2022 | 40 | $91.3M |
| Q2 2022 | 38 | $75.9M |
| Q1 2022 | 37 | $90.1M |
| Q4 2021 | 33 | $80.0M |
| Q3 2021 | 31 | $107.9M |
| Q2 2021 | 38 | $97.9M |
| Q1 2021 | 46 | $114.1M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding scPharmaceuticals Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 66 | $0 | 0.00% | +5+8.2% | Added |
| BNP Paribas Arbitrage, SA | 106 | $511 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 715 | $3.00K | 0.00% | −174−19.6% | Reduced |
| Bank of America Corp | 1,000 | $5.00K | 0.00% | −39−3.8% | Reduced |
| Group One Trading, L.P. | 1,322 | $6.00K | 0.00% | +668+102.1% | Added |
| UBS Group AG | 2,152 | $10.0K | 0.00% | +1,152+115.2% | Added |
| Royal Bank of Canada | 2,056 | $10.0K | 0.00% | +2,000+3,571.4% | Added |
| Advisor Group Holdings, Inc. | 2,663 | $13.0K | 0.00% | −974−26.8% | Reduced |
| Tower Research Capital LLC (TRC) | 6,496 | $31.0K | 0.00% | +6,396+6,396.0% | Added |
| Sandy Cove Advisors, LLC | 10,592 | $51.0K | 0.05% | 00.0% | Unchanged |
| Virtu Financial LLC | 10,999 | $53.0K | 0.00% | +10,999 | New |
| Wolverine Trading, LLC | 13,770 | $68.0K | 0.00% | +13,770 | New |
| IPG Investment Advisors LLC | 14,300 | $69.0K | 0.02% | 00.0% | Unchanged |
| Thomasville National Bank | 15,000 | $72.0K | 0.01% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 15,530 | $74.0K | 0.00% | +15,530 | New |
| State Street Corp | 17,360 | $84.0K | 0.00% | +2,260+15.0% | Added |
| Bank of New York Mellon Corp | 34,206 | $165.0K | 0.00% | −397−1.1% | Reduced |
| Millennium Management LLC | 36,216 | $175.0K | 0.00% | +11,445+46.2% | Added |
| Zacks Investment Management | 36,989 | $178.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 47,234 | $228.0K | 0.00% | +15,740+50.0% | Added |
| Northern Trust Corp | 48,106 | $232.0K | 0.00% | −802−1.6% | Reduced |
| Simplex Trading, LLC | 59,915 | $288.0K | 0.01% | +36,759+158.7% | Added |
| BlackRock Inc. | 64,788 | $313.0K | 0.00% | +6,905+11.9% | Added |
| Susquehanna International Group, LLP | 72,623 | $350.0K | 0.00% | +31,934+78.5% | Added |
| Geode Capital Management, LLC | 78,574 | $378.0K | 0.00% | +9,322+13.5% | Added |
| Boothbay Fund Management, LLC | 85,462 | $412.0K | 0.01% | −1,173−1.4% | Reduced |
| Morgan Stanley | 95,703 | $461.0K | 0.00% | +9,118+10.5% | Added |
| Dimensional Fund Advisors LP | 116,442 | $561.0K | 0.00% | +12,908+12.5% | Added |
| Bridgeway Capital Management, LLC | 132,200 | $637.0K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 191,586 | $923.0K | 0.00% | +5,500+3.0% | Added |
| Belvedere Trading LLC | 239,219 | $1.27M | 1.38% | +78,337+48.7% | Added |
| Worth Venture Partners, LLC | 335,985 | $1.78M | 1.08% | −12,440−3.6% | Reduced |
| Vanguard Group Inc | 616,558 | $2.97M | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 884,008 | $4.26M | 1.77% | −86,090−8.9% | Reduced |
| AIGH Capital Management LLC | 1,346,724 | $6.49M | 2.70% | −50,000−3.6% | Reduced |
| Armistice Capital, LLC | 2,700,000 | $13.0M | 0.33% | +2,700,000 | New |
| 5AM Venture Management, LLC | 3,561,474 | $17.2M | 4.25% | −270,000−7.0% | Reduced |
| OrbiMed Advisors LLC | 4,797,148 | $23.1M | 0.45% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −2,658,583−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −67,500−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −10,228−100.0% | Sold out |